RT Journal Article ID 0577b9c2479fbde5 A1 Lin, Abraham A1 Truong, Billy A1 Fridman, Gregory A1 Fridman, Alexander A. A1 Miller, Vandana T1 Immune Cells Enhance Selectivity of Nanosecond-Pulsed DBD Plasma Against Tumor Cells JF Plasma Medicine JO PMED YR 2017 FD 2017-07-27 VO 7 IS 1 SP 85 OP 96 K1 Nanosecond-Pulsed Plasma K1 Tumor Cells K1 Immune Cells K1 Selectivity K1 Macrophage K1 Immunotherapy AB Cancer immunotherapy is a promising strategy that engages the patient's immune system to kill cancer cells selectively while sparing normal tissue. Treatment of macrophages with a nanosecond-pulsed dielectric barrier discharge directly enhanced their cytotoxic activity against tumor cells but not normal cells. These results underscore the clinical potential of plasma for cancer immunotherapy. PB Begell House LK https://www.dl.begellhouse.com/journals/5a5b4a3d419387fb,0372ac1f554f3106,0577b9c2479fbde5.html